Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
129
NCT00788424
Topical Application of AS101 for the Treatment of Psoriasis
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2008
Completion: Feb 28, 2010
NCT00927212
Topical Application of AS101 for the Treatment of Atopic Dermatitis
Start: Jun 30, 2009
Completion: Sep 30, 2010
NCT00926354
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
Start: Aug 31, 2009
Completion: Aug 31, 2010
NCT01555112
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
Phase: Phase 1/2
Start: Mar 31, 2012
Completion: Jul 31, 2013
NCT01010373
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
Start: Jan 31, 2015
Completion: Jan 31, 2016
NCT01943630
Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts
Completion: May 31, 2017